Clinical Trial Update: Frontline Therapy in de Novo Multiple Myeloma Patients Under 65 [Phase 2]

View source ↗

Summary

A Phase 2 frontline therapy study for de novo multiple myeloma patients under 65 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED